Key Insights

Highlights

Treatment Research

1 treatments under study, led by Norepinephrine

Research Leaders

5 sponsors active, led by Hospital Universitário Cassiano Antônio de Moraes/HUCAM

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 3 trials

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 4 (1)

Trial Status

Recruiting2
Active Not Recruiting1

Clinical Trials (3)

Showing 3 of 3 trials
NCT03281317Active Not RecruitingPrimary

Vasoplegic Syndrome in Cardiac Surgery

NCT07059715RecruitingPrimary

Mic Mac: Micro- and Macrocirculatory Assessment During Cardiac Surgery in Patients at Risk of Vasoplegic Syndrome: A Prospective Study.

NCT06934798Phase 4RecruitingPrimary

Inotropic Effects of Vasopressin Versus Noradrenaline In Patients With Vasoplegic Syndrome After Cardiac Surgery

Showing all 3 trials

Research Network

Common Treatments

  • Norepinephrine1

Active Sponsors

  • Hospital Universitário Cassiano Antônio de Moraes/HUCAM1
  • Hospital Santa Casa de Misericórdia de Vitória1
  • University of Sao Paulo1
  • European Georges Pompidou Hospital1
  • Centre Hospitalier Universitaire, Amiens1

Top Investigators

Activity Timeline